- Home
- MASI vs ELAN Comparison
MASI vs ELAN Comparison
Compare MASI & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASI
- ELAN
- Stock Information
- Founded
- MASI 1989
- ELAN 1954
- Country
- MASI United States
- ELAN United States
- Employees
- MASI N/A
- ELAN N/A
- Industry
- MASI Medical/Dental Instruments
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- MASI Health Care
- ELAN Health Care
- Exchange
- MASI Nasdaq
- ELAN Nasdaq
- Market Cap
- MASI 8.9B
- ELAN 7.2B
- IPO Year
- MASI 2007
- ELAN 2018
- Fundamental
- Price
- MASI $156.02
- ELAN $14.13
- Analyst Decision
- MASI Buy
- ELAN Buy
- Analyst Count
- MASI 6
- ELAN 7
- Target Price
- MASI $187.00
- ELAN $16.17
- AVG Volume (30 Days)
- MASI 510.5K
- ELAN 4.1M
- Earning Date
- MASI 08-05-2025
- ELAN 08-07-2025
- Dividend Yield
- MASI N/A
- ELAN N/A
- EPS Growth
- MASI N/A
- ELAN N/A
- EPS
- MASI N/A
- ELAN 0.75
- Revenue
- MASI $2,126,800,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- MASI N/A
- ELAN $4.33
- Revenue Next Year
- MASI $7.74
- ELAN $4.75
- P/E Ratio
- MASI N/A
- ELAN $19.20
- Revenue Growth
- MASI 16.68
- ELAN 1.42
- 52 Week Low
- MASI $101.61
- ELAN $8.02
- 52 Week High
- MASI $194.88
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- MASI 41.87
- ELAN 44.72
- Support Level
- MASI $153.36
- ELAN $14.61
- Resistance Level
- MASI $166.96
- ELAN $15.00
- Average True Range (ATR)
- MASI 4.17
- ELAN 0.35
- MACD
- MASI -0.29
- ELAN -0.13
- Stochastic Oscillator
- MASI 19.56
- ELAN 5.80
About MASI Masimo Corporation
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.